Search results
Median overall survival was 9.9 years (95% confidence interval [95% CI] 7.9–11.9). Patients without recurrence experienced longer median survival (not reached) than patients with one or more recurrences (8.92 years) (p < 0.001) and had a high rate (48.8%) of MGMT promoter-unmethylated tumours.
15 lip 2020 · Meta-analyses of real-world data suggested a doubling of 2- and 3-year survival in glioblastoma patients since 2005. However, 5-year survival remains poor with no apparent improvement.
GBM is the most malignant form of primary brain tumor with an extremely poor prognosis. Adult GBM patients with classical treatment have a 5-year survival rate of less than 10%. Our results suggest that patients diagnosed with GBM at an older age have a shorter survival period.
8 gru 2020 · Abstract. In response to major changes in diagnostic algorithms and the publication of mature results from various large clinical trials, the European Association of Neuro-Oncology (EANO)...
19 cze 2019 · After diagnosis, the survival rate at 12, 24, 36, and 48 months was 38%, 16%, 9%, and 6%, respectively. The median survival rate was 8.1 months in all patients (95% CI, 8.0-8.2 months). Figure 2 displays survival curves for the entire population meeting the inclusion criteria.
Glioblastoma multiforme (GBM) is an aggressive primary brain tumor with most dismal survival rates. This study aims to examine the prognostic value of primary tumor sites and race on survival outcomes. Methods.
4 sie 2006 · With optimal treatment, patients with GBs have a median survival of less than one year. 1 About 2% of patients survive three years. 4 Previously reported long-term survivors (LTSs) of GB may have been patients who actually harbored other low-grade gliomas. 5 The overall prognosis for GB has changed little since the 1980s, despite major ...
